Journal article
Analysis of INSPPIRE-2 Cohort: Risk Factors and Disease Burden in Children With Acute Recurrent or Chronic Pancreatitis
Journal of pediatric gastroenterology and nutrition, Vol.75(5), pp.643-649
11/01/2022
DOI: 10.1097/MPG.0000000000003590
PMCID: PMC9617760
PMID: 35976273
Abstract
OBJECTIVESThe objective of this study is to investigate risk factors and disease burden in pediatric acute recurrent pancreatitis (ARP) and chronic pancreatitis (CP). METHODSData were obtained from INternational Study group of Pediatric Pancreatitis: In search for a cuRE-2 (INSPPIRE-2), the largest multi-center prospective cohort study in pediatric patients with ARP or CP. RESULTSOf 689 children, 365 had ARP (53%), 324 had CP (47%). CP was more commonly associated with female sex, younger age at first acute pancreatitis (AP) attack, Asian race, family history of CP, lower BMI%, genetic and obstructive factors, PRSS1 mutations and pancreas divisum. CFTR mutations, toxic-metabolic factors, medication use, hypertriglyceridemia, Crohn disease were more common in children with ARP. Constant or frequent abdominal pain, emergency room (ER) visits, hospitalizations, medical, endoscopic or surgical therapies were significantly more common in CP, episodic pain in ARP. A total of 33.1% of children with CP had exocrine pancreatic insufficiency (EPI), 8.7% had diabetes mellitus. Compared to boys, girls were more likely to report pain impacting socialization and school, medical therapies, cholecystectomy, but no increased opioid use. There was no difference in race, ethnicity, age at first AP episode, age at CP diagnosis, duration of disease, risk factors, prevalence of EPI or diabetes between boys and girls. Multivariate analysis revealed that family history of CP, constant pain, obstructive risk factors were predictors of CP. CONCLUSIONSChildren with family history of CP, constant pain, or obstructive risk factors should raise suspicion for CP.
Details
- Title: Subtitle
- Analysis of INSPPIRE-2 Cohort: Risk Factors and Disease Burden in Children With Acute Recurrent or Chronic Pancreatitis
- Creators
- Aliye UcGretchen A CressFuchenchu WangMaisam Abu-El-HaijaKate M ElleryDouglas S FishmanCheryl E GariepyTanja GonskaTom K LinQuin Y LiuMegha MehtaAsim MaqboolBrian A McFerronVeronique D MorinvilleChee Y OoiEmily R PeritoSarah Jane SchwarzenbergZachary M SellersJose SerranoUzma ShahDavid M TroendleMichael WilschanskiYuhua ZhengYing YuanMark E Lowe
- Resource Type
- Journal article
- Publication Details
- Journal of pediatric gastroenterology and nutrition, Vol.75(5), pp.643-649
- DOI
- 10.1097/MPG.0000000000003590
- PMID
- 35976273
- PMCID
- PMC9617760
- NLM abbreviation
- J Pediatr Gastroenterol Nutr
- ISSN
- 0277-2116
- eISSN
- 1536-4801
- Grant note
- DOI: 10.13039/100000002, name: National Institutes of Health, award: 2U01 DK108334, 2U01 DK108328, R01 DK118752; DOI: 10.13039/100011022, name: Vertex Pharmaceuticals
- Language
- English
- Date published
- 11/01/2022
- Academic Unit
- Stead Family Department of Pediatrics; Radiation Oncology; Gastroenterology, Hepatology, Pancreatology, and Nutrition
- Record Identifier
- 9984313082602771
Metrics
64 Record Views